Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Optivate, formerly EyeMD EMR Healthcare Systems, is a specialty healthcare technology company focused on software and services for ophthalmology practices and eye care providers. Its core offerings include ophthalmology-specific electronic medical records, practice management, imaging, patient engagement, and revenue cycle management tools, along with medical billing services through its subsidiary Abillifeye. The platform is designed specifically for ophthalmic workflows and subspecialties such as retina, cornea, pediatric ophthalmology, and glaucoma. The company appears to be commercially established, privately held, and backed by Performant Capital following a majority investment/acquisition in April 2025. In September 2025 the company announced a rebrand from EyeMD EMR to Optivate, with the new brand officially launched in March 2026.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Optivate.